Lv1
10 积分 2022-07-19 加入
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
4小时前
已完结
NASH drug treatment development: challenges and lessons
4小时前
已完结
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
4小时前
已完结
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
5个月前
已完结
NASH drug treatment development: challenges and lessons
5个月前
已完结
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
6个月前
已完结
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma
7个月前
已完结
Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD
9个月前
已完结
Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice
9个月前
已完结
DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2
10个月前
已完结
皖公网安备34019202002308
